Sales decline 18.82% to Rs 86.89 crore
Net Loss of Sterling Biotech reported to Rs 109.51 crore in the quarter ended September 2016 as against net loss of Rs 94.21 crore during the previous quarter ended September 2015. Sales declined 18.82% to Rs 86.89 crore in the quarter ended September 2016 as against Rs 107.03 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales86.89107.03 -19 OPM %-7.4013.89 -PBDT-101.74-69.25 -47 PBT-167.47-139.46 -20 NP-109.51-94.21 -16Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
